Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BioCardia, Inc. Director's Dealing 2016

Mar 24, 2016

35081_dirs_2016-03-24_d882261e-8bc7-4e09-adca-19ca08869227.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: Tiger X Medical, Inc. (CDOM)
CIK: 0000925741
Period of Report: 2012-12-31

Reporting Person: Brooks Andrew A (Director, CEO, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-12-31 Common Stock P 680034 $0.067 Acquired 62559223 Direct

Footnotes

F1: On January 2, 2013, the reporting person mistakenly reported the number of securities purchased and the price of the shares. The number of shares purchased and price per share are corrected in this Form 4.